Two deaths reported to FDA after black-market retatrutide use
Both FAERS reports came from health professionals and involved cardiac arrest in patients who obtained the unapproved Lilly candidate outside clinical trials.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 19 03:00 ETSource: Partnership for Safe Medicines
The wire
- 01A 41-year-old woman died in July after cardiac arrest following compounded retatrutide from what the report calls an unreliable source; a 49-year-old died in September after severe dehydration, malnutrition and cardiac arrest.
- 02Retatrutide is not legally available outside Eli Lilly programs, so clinicians seeing patients on it are dealing with gray-market material of unverified dose and content.
- 03A separate analysis of roughly 150,000 social posts from 13,500 users of unapproved retatrutide logged increased appetite, fatigue, insomnia and heart-rate rises, with psychiatric symptoms reported by 30%; FAERS reports are voluntary and unverified.
From the source
Read at safemedicines.orgOctober 19, 2026: Two deaths linked to bootlegged retatrutide
Two deaths have been linked to black market versions of retatrutide, as a British woman warns followers that taking an early dose of the drug “nearly killed” her.
